Weekly IDEXX Laboratories, Inc. (NASDAQ:IDXX) Ratings on May 16, 2018

May 16, 2018 - By Mark Mitchell

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Corporate Logo
Big Money Sentiment decreased to 0.81 in Q4 2017. It has change of 0.05, from 2017Q3’s 0.86. The ratio fall due to IDEXX Laboratories, Inc. positioning: 30 sold and 217 reduced. 64 funds amassed positions and 137 increased positions. Investors holded 87.85 million in 2017Q3 but now own 72.13 million shares or 17.89% less.
Meag Munich Ergo Kapitalanlagegesellschaft Mbh has invested 0.03% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Utd Automobile Association holds 0.03% or 62,600 shs. Bbva Compass Bancshares holds 2,068 shs or 0.02% of its capital. Sumitomo Mitsui Asset Mgmt Company Ltd invested 0.01% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Fuller And Thaler Asset Mngmt, a California-based fund reported 28,085 shs. Hsbc Hldgs Public Limited Co owns 0.02% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 80,931 shs. Comerica Bancorporation reported 25,944 shs or 0.03% of all its holdings. California-based Mogy Joel R Counsel has invested 1.23% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). 1.02 million are held by Northern Corp. Bath Savings Tru Communication holds 30,304 shs or 1.19% of its capital. Inv House has 1,850 shs for 0.04% of their capital. Putnam Fl Inv Communication owns 4,849 shs for 0.07% of their capital. Invesco holds 960,463 shs or 0.05% of its capital. Brown Brothers Harriman stated it has 2,216 shs. Ls Inv Advsr Ltd Liability Corporation invested 0.04% in IDEXX Laboratories, Inc. (NASDAQ:IDXX).

IDEXX Laboratories, Inc. registered $23.44 million net activity with 2 buys and 7 sales since January 9, 2018. Another trade for 54,000 shs valued at $8.96M was sold by AYERS JONATHAN W. On Wednesday, February 14 the insider Kingsley Lawrence D bought $178,045. On Thursday, May 10 END WILLIAM T sold $1.97M worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX). Shares for $1.20 million were sold by MCKEON BRIAN P. $179,580 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) shs were bought by Claflin Bruce L..

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Ratings Coverage

In total 5 analysts cover IDEXX Laboratories (NASDAQ:IDXX). “Buy” rating has 5, “Sell” are 0, while 0 are “Hold”. (NASDAQ:IDXX) has 100% bullish analysts. 7 are the (NASDAQ:IDXX)’s ratings reports on May 16, 2018 according to StockzIntelligence Inc. In Monday, May 7 report Stifel Nicolaus maintained it with “Buy” rating and $225 target. In Monday, January 29 report Canaccord Genuity maintained the stock with “Buy” rating. On Thursday, February 1 the stock has “Buy” rating by Stifel Nicolaus. On Friday, February 2 the stock has “Buy” rating by Bank of America. On Monday, May 7 Canaccord Genuity maintained IDEXX Laboratories, Inc. (NASDAQ:IDXX) rating. Canaccord Genuity has “Buy” rating and $22500 target. Listed here are IDEXX Laboratories, Inc. (NASDAQ:IDXX) PTs and latest ratings.

07/05/2018 Broker: Canaccord Genuity Rating: Buy New Target: $225.0000 Maintain
07/05/2018 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Buy Old Target: $215 New Target: $225 Maintain
02/02/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $200 New Target: $220 Maintain
01/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $215.0 Maintain
01/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $211.0
29/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $210.0 Maintain
16/01/2018 Broker: PiperJaffray Rating: Overweight New Target: $200 Initiates Coverage On

IDXX is hitting $199.54 during the last trading session, after decreased 4.49%.IDEXX Laboratories, Inc. has 1.12 million shares volume, 139.04% up from normal. IDXX is uptrending and has moved 23.99% since May 16, 2017. The stock outperformed the S&P 500 by 12.44%.

IDEXX Laboratories, Inc., together with its subsidiaries, develops, makes, and distributes services and products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.The firm is worth $17.33 billion. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other divisions.67.87 is the P/E ratio. The firm provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

More recent IDEXX Laboratories, Inc. (NASDAQ:IDXX) news were brought out by Seekingalpha.com, Nasdaq.com and Fool.com. The first one has “Buy Diamondback Energy On Declines – Cramer’s Lightning Round (5/11/18)” as a title and was brought out on May 14, 2018. The next is “IDEXX Laboratories Barks Out Another Successful Quarter” on May 11, 2018. And last was brought out on May 10, 2018, called “The 3 Stocks on the MFM Team’s Radar This Week”.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: